Physician profile
Mrunalini Gopalam
NPI 1184814808
$1,577.92
in general payments reported to CMS, 2019-2025
22 companies · $87.45 in 2025
The $87.45 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $66.39 · 2021: $207 · 2022: $286 · 2023: $153 · 2024: $252 · 2025: $87.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $190.66 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $180.79 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $179.29 | 2019-2024 | Rexulti |
| Glaxosmithkline, LLC. | $130.08 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $106.37 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $92.90 | 2021-2023 | Trintellix |
| Abbvie INC. | $86.96 | 2022-2024 | |
| Shire North American Group INC | $41.57 | 2019 | |
| Exact Sciences Corporation | $36.61 | 2023-2024 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $30.44 | 2024 | Horizant |
| Sanofi Pasteur INC. | $27.57 | 2019 | |
| Genentech USA, INC. | $15.00 | 2019 | |
| Currax Pharmaceuticals LLC | $14.81 | 2025 | Contrave |
| Cranial Technologies, INC | $14.67 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $14.54 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.90 | 2022 | |
| Amgen INC. | $13.59 | 2019 | |
| Lilly USA, LLC | $12.98 | 2019 | |
| Lundbeck LLC | $12.24 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.19 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mrunalini Gopalam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.